Strata Critical Medical (SRTA) Income from Continuing Operations (2019 - 2026)

Strata Critical Medical has disclosed Income from Continuing Operations across 8 years of filings, most recently posting 2402000.0 for Q1 2026.

• In Q1 2026, Income from Continuing Operations rose 249.01% year-over-year to 2402000.0; the TTM figure through Mar 2026 stood at 16386000.0 (up 36.96% YoY), while the FY2025 annual figure was 20066000.0, down 24.16% from the prior year.
• Income from Continuing Operations advanced to 2402000.0 in Q1 2026, from 5388000.0 in the prior quarter.
• Over the last five years, Income from Continuing Operations for SRTA reached as high as 8412000.0 in Q2 2022 and fell as low as 33941000.0 in Q4 2023.
• The 5-year median for Income from Continuing Operations is 5627000.0 (2024), against an average of 7019400.0.
• Annual changes were most pronounced in 2024 — Income from Continuing Operations plunged 2047.06% — and 2026, when it jumped 249.01%.
• A 5-year view of Income from Continuing Operations shows it stood at 8412000.0 in 2022, then plunged by 503.48% to 33941000.0 in 2023, then surged by 78.11% to 7430000.0 in 2024, then advanced by 27.48% to 5388000.0 in 2025, then jumped by 144.58% to 2402000.0 in 2026.
• According to Business Quant data, Income from Continuing Operations over the past three periods registered 2402000.0, 5388000.0, and 9657000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.